Cite
ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes.
MLA
Chen, Ye-Hui, et al. “ARPC1A Correlates with Poor Prognosis in Prostate Cancer and Is Up-Regulated by Glutamine Metabolism to Promote Tumor Cell Migration, Invasion and Cytoskeletal Changes.” Cell & Bioscience, vol. 13, no. 1, Feb. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s13578-023-00985-w.
APA
Chen, Y.-H., Chen, H., Lin, T.-T., Zhu, J.-M., Chen, J.-Y., Dong, R.-N., Chen, S.-H., Lin, F., Ke, Z.-B., Huang, J.-B., Wei, Y., Zheng, Q.-S., Xue, X.-Y., & Xu, N. (2023). ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes. Cell & Bioscience, 13(1), 1–16. https://doi.org/10.1186/s13578-023-00985-w
Chicago
Chen, Ye-Hui, Hang Chen, Ting-Ting Lin, Jun-Ming Zhu, Jia-Yin Chen, Ru-Nan Dong, Shao-Hao Chen, et al. 2023. “ARPC1A Correlates with Poor Prognosis in Prostate Cancer and Is Up-Regulated by Glutamine Metabolism to Promote Tumor Cell Migration, Invasion and Cytoskeletal Changes.” Cell & Bioscience 13 (1): 1–16. doi:10.1186/s13578-023-00985-w.